Post-approval studies (Phase 4)UnknownNCT02402491
What this trial is testing
Twelve vs 24 Months of Dual Antiplatelet Therapy in Patients With Coronary Revascularization for In-stent Restenosis
Who this might be right for
Percutaneous Coronary Intervention
Beijing Anzhen Hospital 1,000